Member Info for Leapfroggy

And your explanation for the nil sales from the VIPs hat have had the product for over a year? If you have one then that’s a good reason to invest!

Hence the Zen in Zenakine which is actually a great name for a sleep product that improves your skin

Confirmation that Zenakine is being marketed as ‘sleep care’. A substantial market but the ‘hot money’ has gone and the SP retraced as it’s never going to make inroads into Matrixyl and Retinol. I’m hoping for 40p this year, maybe 50p on the launch of the acne product.

Indeed. Unfortunate that my Google search doesn’t register anything for Zinakine and only gives me info on Zinedine!

Zinakine itself

I agree. I have sold half my shares and will continue selling 50,000 a day if the SP continues falling. No one is selling Zinakine so it’s possible the royalty figure to date is low which will cause the SP to plummet. No progress on Acne or the UK retail launch. The company isn’t even selling Zainadine itself. Axisbiotix annual sales about the same as three weeks sales at my Tesco Local.

Not too surprised. I have top sliced £10k of SBTX to buy AURR and INSG which I am putting in the bottom draw. Will sell more SBTX to buy AURR if they go beyond 90.

If I remember rightly the average premium for a take over last year was 36%.

Sorry, should be of course, ‘one person on each long haul overnight flight’. This would be 3.3million night flights out of 11million flights in total

no idea why my reference to ba’s collagen ****tail was asterisked. perhaps they don’t like ****s!

the potential for sales is still massive. let’s presume only one person on an overnight uk long haul flight buys a zenakine mask to arrive relaxed and with skin at least as good as they had when boarding. bas collagen ****tail sells at £30 though with no evidence of its effect. presuming sbtx receives £1 that’s £3.3m p.a. give it free to first class passengers and add another £6m +

And gives meaning to the term ‘beauty sleep’

I agree. The rns refers to the additional benefits and this reference seems to be at the cost of the core benefits which will drive sales. That said Croda should be presumed to be experts at marketing this sort of product. They have positioned Zenakine as an innovative and cutting edge product which is very different from anything else on the market. Something that will grab media and industry attention compared with yet another skin improvement product. I am hoping Das will put everything into context and explain Croda’s thinking and his own market expectations on the 16th.

Add to that: no launch of an in-house product even though that is presumably one of the reasons we bought BTS.

No purchase of shares by directors

SA needs to understand that the SP has dropped because this was an underwhelming commercial launch. None of the VIPs, indeed no one at all is selling the product even though they have had time to formulate and prepare their marketing. I top sliced to take profits as I have far too much of my investments in this company. I also have a rule to start selling when a share drops by 15% and continue if it continues to fall. . That said I believe that there is massive potential and that many companies will want to add the product to their night cream/ face masks.

So why can’t I actually buy this product today if it has been with the VIP clients for a year?

The product is already on sale, so does this mean it’s a competitor product?

At least 10% as, if I remember rightly, we receive an enhanced rate if Croda sells to those companies that SBTX had opened discussions with prior to the Croda agreement.

I suspect that Croda will be launching our and other products to create a market leading position in ‘natural’ white biotechnology' using living cells—from yeast, moulds, bacteria and plants and enzymes to synthesize products that are easily degradable, require less energy and create less waste during their production. Above all, this will consign many existing products to a ‘dirty’ product category.

Just a shame that I tried to buy 25,000 at 21p this morning, when I could probably have bid just a bit higher and made a nice profit. First world problems!